HIV affects the immune system. Testing a small sample of blood can show the health of the immune system and how much HIV is in the blood. Other tests can look at the health of other parts of the body, which may be affected by HIV or other conditions. Some tests use blood samples, but tests can also involve giving a urine or stool sample, or having a scan or X-ray.

Health monitoring: latest news

Health monitoring features

Health monitoring news from aidsmap

More news

Health monitoring news selected from other sources

  • Multi-disease testing offers new ways to streamline disease management, Unitaid report says

    Innovators are responding to the world’s growing co-infection crisis by developing devices that can quickly, accurately diagnose multiple diseases at a time. Unitaid’s new landscape report, launched today, profiles more than 95 such devices, already on the market or in development, all of which address at least one of Unitaid’s key disease areas—HIV, hepatitis C (HCV), tuberculosis (TB) and malaria.

    02 February 2018 | Unitaid
  • Do People With HIV Need Annual Physical Examinations?

    Are yearly comprehensive physical exams a waste of time in people with HIV, or do higher rates of cancer and other clinical conditions merit more intense screening? Clinical practice guidelines don't put this to rest.

    12 July 2017 | The Body PRO
  • Early-capture HIV study allows for characterization of acute infection period

    Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure. In a study by the U.S. Military HIV Research Program (MHRP), Walter Reed Army Institute of Research, published in The New England Journal of Medicine, scientists enrolled and intensively followed a cohort of high-risk individuals, tracking their HIV status and characterizing the disease through the acute stages of HIV infection.

    19 May 2016 | EurekAlert!
  • Unique Health Care Challenges for Older Adults with HIV

    Dr. Meredith Greene, fellow in the Division of Geriatrics at University of California, San Francisco, has spent her career working out how to integrate HIV services and geriatric care. “Traditionally, those areas haven’t overlapped a lot,” she explains—yet as individuals with HIV live longer with increasingly more effective and tolerable HIV therapies, she recognizes the importance of tailoring medical care services for older HIV-positive adults to their unique medical needs.

    17 September 2014 | BETA blog
  • UNITAID technical report: Tuberculosis diagnostics technology and market landscape

    The report reviews the landscape of TB diagnostics - considering current and expected future technologies, as well as critical market issues, highlighting potential market-based approaches to address shortcomings and improve market function.

    11 July 2013 | UNITAID
  • Detecting Kaposi's sarcoma with a smartphone accessory

    Engineers from Cornell University have created a new optical sensor that plugs in to a smartphone and, using disposable microfluidic chips, allows for inexpensive in-the-field diagnosis of Kaposi's sarcoma, a cancer linked to AIDS.

    07 June 2013 | Eurekalert Medicine & Health
  • Handheld mobile device performs laboratory-quality HIV testing

    A new handheld mobile device can check patients’ HIV status with just a finger prick, and synchronize the results in real time with electronic health records.

    21 January 2013 | Science Daily
  • Longer Visit Interval OK in Stable HIV

    Going 4 or 6 months between office visits instead of the standard 3 does not appear to compromise virologic control among stable HIV-infected patients, researchers suggested here.

    24 October 2012 | MedPage Today
  • Research supports longer Pap test intervals for HIV-positive women

    For HIV-positive women, annual Pap testing appears safe, and after three consecutive normal results, a three-year screening interval is appropriate, the Women's Interagency HIV Study (WIHS) investigators advise in a new report.

    01 October 2012 | ModernMedicine
  • Can simple blood tests predict liver cancer?

    FIB-4 could represent a relatively cheap and simple way of screening people with HBV, HCV and other risk factors for the possibility of liver cancer.

    18 November 2011 | CATIE
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.